HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Heinz Kutzner Selected Research

Lipids

12/2006Localized panniculitis secondary to subcutaneous glatiramer acetate injections for the treatment of multiple sclerosis: a clinicopathologic and immunohistochemical study.
6/2005Carcinoid-like pattern in sebaceous neoplasms: another distinctive, previously unrecognized pattern in extraocular sebaceous carcinoma and sebaceoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Heinz Kutzner Research Topics

Disease

39Neoplasms (Cancer)
07/2022 - 05/2002
15Melanoma (Melanoma, Malignant)
04/2022 - 11/2003
9Carcinoma (Carcinomatosis)
09/2021 - 03/2002
6Infections
01/2022 - 02/2007
6Lymphoma (Lymphomas)
01/2018 - 05/2002
4Granuloma
01/2022 - 12/2006
4Nevus (Nevi)
10/2008 - 11/2003
3Dermatofibrosarcoma
07/2021 - 07/2015
3Cysts
10/2020 - 12/2008
3Inflammation (Inflammations)
01/2020 - 01/2009
3Basal Cell Carcinoma (Rodent Ulcer)
06/2018 - 05/2009
3Blue Nevus
01/2017 - 02/2002
3Skin Diseases (Skin Disease)
02/2016 - 07/2005
3Pigmented Nevus (Melanocytic Nevus)
11/2010 - 04/2004
3Hyperplasia
04/2009 - 10/2005
3Lymphoproliferative Disorders (Lymphoproliferative Disorder)
02/2009 - 05/2002
2Sarcoma (Soft Tissue Sarcoma)
07/2022 - 07/2015
2Metaplasia
09/2019 - 10/2009
2Erythema Infectiosum (Fifth Disease)
02/2018 - 12/2011
2Neoplasm Metastasis (Metastasis)
09/2017 - 04/2003
2Necrosis
09/2017 - 02/2010
2Myxoma (Myxomas)
09/2017 - 07/2015
2Fibroma (Fibromatosis)
01/2017 - 07/2015
2Halo Nevus
05/2015 - 04/2004
2Pseudolymphoma
03/2015 - 10/2006
2Sarcoidosis (Schaumann Disease)
10/2011 - 08/2007
2Cicatrix (Scar)
10/2009 - 05/2004
2Renal Insufficiency (Renal Failure)
10/2009 - 06/2003
2Nephrogenic Fibrosing Dermopathy
10/2009 - 06/2003
2T-Cell Lymphoma (Lymphoma, T Cell)
06/2008 - 05/2002
2Hemangioma (Angioma)
02/2006 - 05/2004
2Disease Progression
04/2003 - 05/2002
2Breast Neoplasms (Breast Cancer)
06/2002 - 03/2002
1Hypoxia (Hypoxemia)
07/2022
1Inborn Genetic Diseases (Disease, Hereditary)
01/2022
1Chickenpox
01/2022
1Measles
01/2022
1Mumps
01/2022
1Skin Neoplasms (Skin Cancer)
10/2021
1Severe combined immunodeficiency due to adenosine deaminase deficiency
07/2021
1Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)
07/2021
1Lymphatic Metastasis
01/2021
1Lichen Planus (Lichen Ruber Planus)
10/2020
1Lichen planus follicularis
10/2020
1Prurigo
01/2020
1Angiomatosis
01/2020
1Lipoma (Lipomata)
09/2019
1Warts (Wart)
04/2019
1Neurothekeoma
01/2019
1Epithelioid Hemangioendothelioma
01/2019
1Angiolymphoid Hyperplasia with Eosinophilia
01/2019
1Mucinous Adenocarcinoma (Mucinous Carcinoma)
06/2018
1Epidermolysis Bullosa
06/2018
1Ectodermal Dysplasia (Aplasia Cutis Congenita)
06/2018
1Epidermolysis bullosa with pyloric atresia
06/2018

Drug/Important Bio-Agent (IBA)

14Proteins (Proteins, Gene)FDA Link
07/2022 - 03/2003
6CollagenIBA
09/2019 - 07/2005
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2022 - 12/2019
5AntibodiesIBA
01/2019 - 03/2003
5Coloring Agents (Dyes)IBA
01/2019 - 01/2006
5Melanins (Melanin)IBA
02/2010 - 02/2002
4Biomarkers (Surrogate Marker)IBA
10/2021 - 05/2013
4S100 Proteins (S 100 Protein)IBA
01/2019 - 05/2003
4ParaffinIBA
02/2018 - 04/2004
4VimentinIBA
03/2017 - 08/2002
4Phosphotransferases (Kinase)IBA
05/2016 - 01/2014
3Keratins (Keratin)IBA
10/2020 - 12/2008
3DNA (Deoxyribonucleic Acid)IBA
04/2019 - 11/2005
3DesminIBA
01/2019 - 01/2006
3MucinsIBA
06/2018 - 09/2006
3AntigensIBA
03/2017 - 09/2009
3CalponinsIBA
03/2017 - 05/2003
3MART-1 AntigenIBA
11/2015 - 02/2006
3T-Cell Antigen Receptors (T-Cell Receptor)IBA
10/2011 - 10/2005
3Formaldehyde (Formol)FDA Link
11/2006 - 04/2004
2Calmodulin-Binding Proteins (Caldesmon)IBA
03/2017 - 01/2006
2Perilipin-2IBA
03/2017 - 11/2015
2Syntex adjuvant formulationIBA
01/2017 - 07/2015
2Phenobarbital (Luminal)FDA Link
10/2015 - 10/2007
2Monoclonal AntibodiesIBA
01/2015 - 04/2004
2Hematoxylin (Haematoxylon)IBA
10/2010 - 01/2006
2Eosine Yellowish-(YS) (Eosin)IBA
10/2010 - 01/2006
2LipidsIBA
12/2006 - 06/2005
2Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA
10/2006 - 10/2005
2Mucin-1 (CA 15-3 Antigen)IBA
02/2006 - 10/2005
1Oxygen (Dioxygen)IBA
07/2022
1Glucose (Dextrose)FDA LinkGeneric
04/2022
1VaccinesIBA
01/2022
1Attenuated VaccinesIBA
01/2022
1Rubella VaccineIBA
01/2022
1GlycogenIBA
01/2021
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
08/2020
1Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA
08/2020
1Angiogenesis Inducing Agents (Angiogenesis Factor)IBA
01/2020
1Vascular Endothelial Growth FactorsIBA
01/2020
1Polytetrafluoroethylene (Teflon)FDA Link
01/2019
1Viral ProteinsIBA
02/2018

Therapy/Procedure

5Therapeutics
11/2020 - 04/2003
1Stem Cell Transplantation
07/2021
1Skin Transplantation (Skin Grafting)
06/2018